The Future of Medication Therapy Management: 2025 and Beyond

By Diana Frid, PharmD The Centers for Medicare and Medicaid Services (CMS) have introduced significant updates to Medication Therapy Management (MTM) requirements, reshaping the landscape for Medicare plans, pharmacists, providers, and patients. These changes primarily impact patient eligibility and the delivery of Comprehensive Medication Reviews (CMRs). While they will not immediately affect Star Ratings, they […]
Addressing the Growing Epidemic of Falls Among Seniors: How GalenusRx Can Help

In the November 30, 2024, Wall Street Journal article, “Why Does America’s Falling Epidemic Keep Getting Worse?” author Peter Funt offers a compelling analysis of why Americans fall and explains why the problem continues to escalate. Falls among seniors remain a pressing public health concern, with more than one in four individuals aged 65 and […]
My Doctor Says I Need 5-FU: What Should I Do?

The NIH estimates that roughly 275,000 cancer patients in the U.S. receive 5-FU, or chemotherapy drug 5-fluorouracil, annually. Up to 3% of those patients experience a toxic reaction. If your oncologist recommends 5-FU as a cancer treatment, you’ll likely have a lot of questions. “Does this treatment make the most sense for my cancer?” “What […]
The Impact of Community Pharmacy Reimbursement

How did we get here, and what does it mean for the future of pharmacy practice?